Recently, MSCs overexpressing IL-10 showed immunosuppressive properties and reduced inflammation in experimental airway inflammation.35 Clinical grade IL-10 reduced inflammation in inflammatory bowel disease trials.36 It is, therefore, conceivable that expanding and transferring MSCs in the presence of an IL-10–enriched medium could restore the therapeutic qualities of MSCs from pwMS. Here, IL10 is linked to inflammatory bowel disease.